ARCHIVES

FDA Advisory Committee To Consider NDAs On Novantrone, HD MTX

This article is from The Cancer Letter archive.

Vol. 13 No. 46 | November 27, 1987

Download PDF Visit The Full Archive

Related Articles

US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma.

July 28, 2000

Impath Buys Clinical Studies Support Services Network.

September 28, 2001

Senate Passes Non-Binding Resolution To Double NIH Budget Over Five Years

May 23, 1997

Garb’s Questions, Answers About Cancer Program

December 5, 1980

MRI Predicts If Chemo Working In Preoperative Therapy

February 25, 2005

In Turnaround, NCAB To Advise Screening Mammography for Women In Their Forties

March 28, 1997